GSITGSI Technology, Inc.
The schedule
- Tue20Oct
Policy updates from President Trump’s administration on US-China semiconductor export controls, which could affect GSIT’s addressable market and supply-chain risk depending on the scope of restrictions on AI and memory components.
- Thu5Nov
Q3 2026 earnings release, where investors will scrutinize whether GSIT can re-accelerate revenue from the current ~$6.3M quarterly plateau and show any leverage in operating losses while sustaining AI and Gemini-III investment.
- Mon1Feb
Q4 2026 earnings release, likely including an updated view on FY2027 AI accelerator roadmaps and cash burn trajectory, which will be critical for reassessing GSIT’s ability to fund Gemini-III development without highly dilutive capital raises.
- Thu25Mar
Potential announcement of a strategic partnership, minority investment, or outright M&A interest in GSIT’s AI accelerator and specialty memory assets, which could re-rate the stock around strategic optionality and balance-sheet support.
- Mon26Apr
- Mon19Jul
Q2 2027 earnings release, by which time the market will expect either visible AI revenue ramps or a clearer strategic path following any partnership or M&A discussions earlier in the year.
Past
- Tue15Sep
Potential announcement of a meaningful APU or AI accelerator design win for Gemini-III, where confirmation of a Tier-1 data-center, networking, or defense customer could re-rate GSIT as a real AI attach rather than a speculative story.
- Thu6Aug
Q1 FY2027 results and AI commercialization commentary around the Gemini-III accelerator, where investors will focus on any early customer traction, backlog visibility, and progress on narrowing quarterly losses from the recent -$0.13 EPS run-rate.
- Thu14May
Actual outcome: Bear · $8.07 at outcome
GSI Technology reported Q4 earnings that met EPS estimates (-$0.13) but highlighted ongoing net losses driven by elevated research and development expenses for its Gemini-III platform. Despite positive announcements, including 22% growth in its SRAM business and new project awards, the market focused on the company's cash burn and high R&D costs, driving the stock down over 25% toward the bear floor.
Market evaluation of Q4 results from an $11.54 base, focusing on APU commercialization progress with a $14.80 upside and $8.00 downside.